To me this is good news.

The science people have come through again in terms of starting a trial. Congrats to them. It was a nail bighter from my perspective.

1. Now we need to have the trial successfully executed.
2. Then we need successful results and moving to the next trial stage unless it somehow gets approval for treatmment at this stage. Then stage Eversana can do their thing.

Not to rain on the parade but the weakest link in the chain remains management. We now need management to step up and do their job.

1. Pay out the debenture. Secure the IP. 
2. Put RVX on a firm financial footing with funding for Covid and BoM2.
3. Find a 3rd partner shareholder, BP or other, to balance the share distribution.
4. Achieve this in a non-dilutive manner that reflects the true underlying value and potential of this science.

I will remain critical of management until I see a change in attitude that shows respect for retail shareholders.

BUT I'll be very happy if this trial succeeds.

We're off and running. GLTA

Toinv